We read with interest the study by Luo et al1 that evaluates the efficacy of tocilizumab (antibody against interleukin-6 [IL-6]) in patients with coronavirus disease 2019 (COVID-19). The authors shared an encouraging experience of utilizing this medication, particularly in patients at risk of develo...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!